Taiwanese (TAIEX) Growth Pharmaceuticals & Biotech Stocks

UPDATED Jun 22, 2025

Discover Taiwanese Pharmaceuticals & Biotech Growth Stocks that are on the TAIEX. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.

134 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield
6919
Caliway Biopharmaceuticals
NT$1,235.0022.9%139.3%NT$192.3bNT$1,185.00PS4733.4xE85.0%n/a
6446
PharmaEssentia
NT$527.000%6.7%NT$173.6bNT$700.50PE45xE57.7%0.2%
4147
TaiMed Biologics
NT$96.202.4%11.0%NT$26.1bNT$141.67PS43.3xE46.1%n/a
6589
EirGenix
NT$62.502.3%-27.4%NT$19.8bNT$116.50PS19.5xE29.5%n/a
6712
Ever Supreme Bio Technology
NT$152.50-1.6%-12.6%NT$13.3bNT$209.09PE30.8xE10.4%3.1%
6472
Bora Pharmaceuticals
NT$800.000.8%4.6%NT$83.3bNT$975.43PE13.9xE1.0%1.8%
1795
Lotus Pharmaceutical
NT$214.50-2.9%-25.4%NT$56.5bNT$357.00PE10.3xE-4.7%2.7%
1720
Standard Chemical & Pharmaceutical
NT$56.10-2.4%-24.1%NT$10.1bNT$73.00PE12.2xn/a5.0%
4160
Genetics Generation Advancement
NT$49.40-0.2%-41.6%NT$1.4bn/aPE27.4xn/a3.7%
6580
TaiRx
NT$23.70-1.0%-41.5%NT$2.6bn/aPS319.1xn/an/a
1762
Chunghwa Chemical Synthesis & Biotech
NT$25.25-8.2%-50.2%NT$2.0bn/aPE98.1xn/a0.8%
1760
Panion & Bf Biotech
NT$70.60-5.2%-27.6%NT$6.1bn/aPE55.6xn/a2.5%
6875
Pharmosa Biopharm
NT$41.30-5.8%-41.4%NT$5.4bn/aPS31.8xn/an/a
6547
Medigen Vaccine Biologics
NT$43.00-6.3%-17.0%NT$14.6bNT$102.00PS21.3xn/an/a
6885
BRIM Biotechnology
NT$40.5021.6%-2.5%NT$5.2bn/aPS12375.4xn/an/a
6550
Polaris Group
NT$36.35-7.4%-49.2%NT$28.9bn/aPS319.4xn/an/a
6610
TWi Biotechnology
NT$10.75-2.3%-21.0%NT$955.2mn/aPB5.4xn/an/a
4170
Vectorite Biomedical
NT$12.45-1.2%-18.4%NT$564.7mn/aPS9.4xn/an/a
6892
Taiwan Bio Therapeutics
NT$33.65-3.2%-16.9%NT$2.9bn/an/an/an/a
6677
Anxo Pharmaceutical
NT$16.50-13.4%-61.8%NT$966.6mn/aPS1xn/a2.4%
6973
U-Neuron Biomedical
NT$33.20-4.2%-34.9%NT$981.1mn/an/an/an/a
4111
Chi Sheng Pharma & Biotech
NT$30.55-6.6%-0.7%NT$1.7bn/aPE15.7xn/a3.3%
6748
ACRO Biomedical
NT$34.75-5.1%24.1%NT$2.2bn/an/an/an/a
6814
Lukas Biomedical
NT$21.55-6.3%-30.7%NT$946.4mn/aPS4.8xn/an/a
Page 1 of 6
OSZAR »